Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
2019 · Journal of Ovarian Research · 84 citations
https://doi.org/10.1186/s13048-018-0475-z
J
Juan Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
172
Papers
2.8K
Citations
27
h-index
67
i10-index
Juan Xu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & Hippo pathway signaling and YAP/TAZ. The author has an h-index of 27, co-authored 147 publications.
ORCID: 0000-0002-1516-5022Papers by this author
worksLncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer
2016 · Scientific Reports · 71 citations
https://doi.org/10.1038/srep38983
Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells
2017 · Journal of Cellular Physiology · 47 citations
https://doi.org/10.1002/jcp.26369
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer
2022 · Journal of Ovarian Research · 44 citations
https://doi.org/10.1186/s13048-022-00988-0
Circ_0001421 facilitates glycolysis and lung cancer development by regulating miR-4677-3p/CDCA3
2020 · Diagnostic Pathology · 41 citations
https://doi.org/10.1186/s13000-020-01048-1
EPHA5 mediates trastuzumab resistance in HER2‐positive breast cancers through regulating cancer stem cell‐like properties
2019 · The FASEB Journal · 31 citations
https://doi.org/10.1096/fj.201701561rrrr
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat